CD8A and non-small cell lung carcinoma: As shown in Fig 4B, DC-based HHP lung cancer vaccine generated from PBMCs of NSCLC patients stimulated significantly higher amount of IFN-γ-producing CD8+ and CD4+ T cells than DC stimulated with poly(I:C) alone or iDC.